Alm. Brand A/S
23.3.2026 12:01:06 CET | Globenewswire | Press release
Alm. Brand Group achieves upgrade to ‘AAA’ ESG Rating from MSCI
Alm. Brand Group achieves upgrade to ‘AAA’ ESG Rating from MSCI
Alm. Brand Group is pleased to announce that MSCI ESG Ratings has upgraded the Group’s ESG rating from ‘A’ to the highest possible ESG-rating of ‘AAA’, designating the company as an industry leader in environmental, social, and governance (ESG) performance.
Corporate social responsibility is an integral part of Alm. Brand Group’s business model and core pillar of the Group’s overall strategy towards 2028.
The upgraded rating reflects the collective efforts of the entire organization and reaffirms Alm. Brand Group’s commitment to driving sustainable value creation for stakeholders.
Contact
Please direct any questions regarding this announcement to:
Investors and equity analysts:
Head of Investor Relations and ESG
Mads Thinggaard
Mobile no. +45 20 25 54 69
Press:
Communications Director
Claus Kappel Christensen
Mobile no. +45 2524 8993
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
SERB Pharmaceuticals23.10.2026 21:01:27 CEST | Press release
SERB Pharmaceuticals Announces Positive Results from the Post-Authorisation Efficacy Study of Idefirix® (imlifidase) Presented at ASN Kidney Week 2026
F. Hoffmann-La Roche Ltd23.10.2026 19:30:00 CEST | Press release
Roche presents interim phase III data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)
TecDo Technology Co., Limited23.10.2026 18:37:22 CEST | Press release
TGC 2026: Tec-Do Launches Navos Pro for Results-Driven AI for Work
CGTN23.10.2026 18:17:10 CEST | Pressemeddelelse
CGTN: Hvad fortæller historien om 'Half a Quilt' (Et halvt vattæppe) os om Kinas nye lange march?
Genmab A/S23.10.2026 17:55:00 CEST | Press release
Genmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom